.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Julphar
Cerilliant
Covington
US Army
Chubb
Fish and Richardson
Farmers Insurance
Mallinckrodt
Deloitte

Generated: June 27, 2017

DrugPatentWatch Database Preview

Aspirin; pentazocine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for aspirin; pentazocine hydrochloride and what is the scope of aspirin; pentazocine hydrochloride freedom to operate?

Aspirin; pentazocine hydrochloride
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for aspirin; pentazocine hydrochloride.

Summary for Generic Name: aspirin; pentazocine hydrochloride

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list21
Clinical Trials: see list3,277
Drug Prices:see low prices
DailyMed Link:aspirin; pentazocine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
TALWIN COMPOUND
aspirin; pentazocine hydrochloride
TABLET;ORAL016891-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: aspirin; pentazocine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
TALWIN COMPOUND
aspirin; pentazocine hydrochloride
TABLET;ORAL016891-001Approved Prior to Jan 1, 19824,105,659► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Mallinckrodt
Cerilliant
Baxter
Medtronic
Covington
McKinsey
Moodys
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot